CMS just announced a nationwide six-month moratorium on new DMEPOS enrollments and changes in majority ownership, along with new transparency measures and expanded fraud prevention
The 2025 Medicare Fee-For-Service Improper Payments Report was just released. The report identified an estimated $28.8 billion in improper payments with a payment error rate of 6.55%,
Effective January 1, 2026, CMS finalized a major shift in how skin substitute products are paid under the OPPS, ASC, and non-facility settings, with coding,
CMS released the CY 2026 OPPS/ASC Final Rule, introducing significant updates to Hospital Price Transparency (HPT) standards that take effect January 1, 2026. These revisions
CMS has released the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Final Rule, confirming several major policy shifts while making notable changes to
The OIG’s recent audit of dermatology providers highlights a critical compliance checkpoint: billing of evaluation & management (E/M) services on the same day as minor
